Synonyms: SAR97276 | SAR97276A | T3
Compound class:
Synthetic organic
Comment: Albitiazolium was the clinical lead from the bisthiazolium series, a novel class of choline analogue with potent antimalarial activity [2-3].
We display the structure of the parent compound, with PubChem and ChEMBL links provided in the table below. However, the INN-assigned compound is in complex with bromide (represented in PubChem CID 11377022) and this compound is used in the experimental data listed under the 'biological activity' tab. The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY. |
|
Classification | |
Compound class | Synthetic organic |
Ligand families/groups | Antimalarial ligands |
IUPAC Name |
2-[3-[12-[5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium-3-yl]dodecyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol |
International Nonproprietary Names | |
INN number | INN |
9162 | albitiazolium bromide |
Synonyms |
SAR97276 | SAR97276A | T3 |
Database Links | |
CAS Registry No. | 321915-72-4 (source: Scifinder) |
ChEMBL Ligand | CHEMBL1183040 |
GtoPdb PubChem SID | 385612169 |
PubChem CID | 11377023 |
Search Google for chemical match using the InChIKey | UZPXHZIQHWKNPF-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | UZPXHZIQHWKNPF |
Search PubMed clinical trials | albitiazolium bromide |
Search PubMed titles | albitiazolium bromide |
Search PubMed titles/abstracts | albitiazolium bromide |
UniChem Compound Search for chemical match using the InChIKey | UZPXHZIQHWKNPF-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | UZPXHZIQHWKNPF-UHFFFAOYSA-N |